TD Private Client Wealth LLC Sells 45 Shares of Mettler-Toledo International, Inc. $MTD

TD Private Client Wealth LLC trimmed its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 21.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 169 shares of the medical instruments supplier’s stock after selling 45 shares during the period. TD Private Client Wealth LLC’s holdings in Mettler-Toledo International were worth $199,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also made changes to their positions in the company. Farther Finance Advisors LLC lifted its position in shares of Mettler-Toledo International by 39.1% in the first quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier’s stock valued at $103,000 after acquiring an additional 25 shares in the last quarter. QRG Capital Management Inc. lifted its position in shares of Mettler-Toledo International by 29.4% in the first quarter. QRG Capital Management Inc. now owns 489 shares of the medical instruments supplier’s stock valued at $577,000 after acquiring an additional 111 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Mettler-Toledo International by 13.3% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,488 shares of the medical instruments supplier’s stock valued at $2,929,000 after acquiring an additional 292 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its position in shares of Mettler-Toledo International by 95.0% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 2,202 shares of the medical instruments supplier’s stock valued at $2,600,000 after acquiring an additional 1,073 shares in the last quarter. Finally, Boston Trust Walden Corp lifted its position in shares of Mettler-Toledo International by 7.1% in the first quarter. Boston Trust Walden Corp now owns 34,610 shares of the medical instruments supplier’s stock valued at $40,871,000 after acquiring an additional 2,296 shares in the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, insider Gerry Keller sold 165 shares of the company’s stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the transaction, the insider owned 94 shares of the company’s stock, valued at approximately $123,012.16. This represents a 63.71% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Thomas P. Salice sold 1,062 shares of the company’s stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the transaction, the director directly owned 283 shares in the company, valued at approximately $368,154.70. This represents a 78.96% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,827 shares of company stock valued at $2,371,208. 0.77% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. Robert W. Baird boosted their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a research report on Monday, August 4th. Bank of America boosted their target price on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a research report on Monday, September 22nd. Barclays began coverage on Mettler-Toledo International in a research report on Tuesday, June 24th. They issued an “overweight” rating and a $1,325.00 target price on the stock. Evercore ISI decreased their target price on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating on the stock in a research report on Monday, August 4th. Finally, Citigroup boosted their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research report on Thursday, August 21st. Five equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $1,325.56.

Mettler-Toledo International Stock Performance

MTD opened at $1,202.72 on Monday. The stock has a market cap of $24.78 billion, a price-to-earnings ratio of 30.46, a P/E/G ratio of 3.61 and a beta of 1.37. The stock’s 50 day moving average price is $1,269.22 and its 200-day moving average price is $1,184.64. Mettler-Toledo International, Inc. has a one year low of $946.69 and a one year high of $1,521.01.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating analysts’ consensus estimates of $9.58 by $0.51. The firm had revenue of $983.22 million for the quarter, compared to analysts’ expectations of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The company’s quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.